Immediate Impact

1 by Nobel laureates 6 from Science/Nature 53 standout
Sub-graph 1 of 19

Citing Papers

The Rotterdam Study. Design update and major findings between 2020 and 2024
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
2 intermediate papers

Works of N. Zander being referenced

Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population
2020
Prevalence, predictors and comorbidity of dry skin in the general population
2018

Author Peers

Author Last Decade Papers Cites
N. Zander 218 69 109 30 386
N. Franzke 300 43 127 18 417
Robert A. Norman 203 65 27 38 412
H. Behrendt 126 25 47 60 421
Dali Yi 185 79 21 17 450
Alan B. Fleischer 294 99 114 16 438
Armin Aryannejad 61 58 28 31 432
J.C. Ruiz‐Carrascosa 185 57 215 33 381
George Gondo 136 24 245 19 352
Sonia A. Lamel 169 102 17 17 371
Melissa Danesh 195 55 118 33 382

All Works

Loading papers...

Rankless by CCL
2026